Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Pain Control for Cervical Ripening Balloon

Study ID: NCT07268118
Start Date: 2026-04
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

110

Intervention / Treatment

topical vaginal application lidocaine gel

Sponsor

Beth Israel Deaconess Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Cognitive-Sensorimotor Function in Long-COVID

Study ID: NCT06850350
Start Date: 2026-04-01
End Date: 2030-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

136

Intervention / Treatment
Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Study ID: NCT07361484
Start Date: 2026-06-01
End Date: 2029-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

442

Intervention / Treatment

Plinabulin

Docetaxel

Placebo (matching plinabulin placebo)

Sponsor

BeyondSpring Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list

Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing

Study ID: NCT07485647
Start Date: 2026-05
End Date: 2029-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Daratumumab and Recombinant Human Hyaluronidase

Lenalidomide

Sponsor

Eden Biltibo

Source: clinicaltrials.gov

Share:
Add to list

On-Demand AI Support Via LINE-Based GPT Assistant to Improve Emotional Resilience and Reduce Burnout Among Clinical Nurses

Study ID: NCT07380685
Start Date: 2026-05-01
End Date: 2026-09-25
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Interactive LINE GPT Emotional Support

Static Supportive Messages

Sponsor

Taipei Medical University Shuang Ho Hospital

Source: clinicaltrials.gov

Share:
Add to list

Glaucoma Exercise as Medicine Study (GEMS).

Study ID: NCT05581498
Start Date: 2026-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Exercise, Bike exercise and muscle strength exercise.

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

Study ID: NCT07436611
Start Date: 2026-04
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Rapamycin cream

Pulsed dyed laser

Sponsor

AFT Pharmaceuticals, Ltd.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

Study ID: NCT07302347
Start Date: 2026-03-31
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Pembrolizumab

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

A Phase I Study of YK012 in Primary Membranous Nephropathy

Study ID: NCT07234474
Start Date: 2026-10
End Date: 2028-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

66

Intervention / Treatment

YK012

Sponsor

Excyte Biopharma Ltd

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Hope@School Prevention Program

Study ID: NCT06359262
Start Date: 2027-01-01
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

3220

Intervention / Treatment

Hope@School

Treatment as usual

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list